✦ LIBER ✦

Lofexidine, an 2-Receptor Agonist for Opioid Detoxification

✍ Scribed by Gish, E. C; Miller, J. L; Honey, B. L; Johnson, P. N

Book ID: 111891855
Publisher: Harvey Whitney Books Company
Year: 2009
Tongue: English
Weight: 180 KB
Volume: 44
Category: Article
ISSN: 1060-0280
DOI: 10.1345/aph.1m347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocular hypotensive effects of lofexidine

Ocular hypotensive effects of lofexidine, an alpha2-adrenoreceptor agonist

✍ Edward E. Elko; Tung Tran; Harbans Lal; Dr. Thomas Yorio 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

The present study examines the ocular hypotensive efficacy end pupillary response of the alpharadrenergic receptor agonists lofexidine and clonidine. The topical administration of lofexidine to rabbit eyes in concentrations ranging from 0.25 to 5%, produced a dosedependent bilateral reduction in int

Regulation of opioid receptors by opioid

Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification

✍ LYNETTE C. DAWS; JASON M. WHITE 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Prison based detoxification for opioid d

Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone

✍ Cliff Howells; Steve Allen; John Gupta; Garry Stillwell; John Marsden; Michael F 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

An Opioid Agonist with Preference for κ-

An Opioid Agonist with Preference for κ-Opioid Receptors: (−)-N-Cyclopropylmethylmorphinan-6-one

✍ Helmut Schmidhammer; Ellen Trenker; Willy P. Burkard; Lislott Eggstein-Aeppli; F 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

A Photochromic Agonist for μ-Opioid Rece

A Photochromic Agonist for μ-Opioid Receptors

✍ Schönberger, Matthias; Trauner, Dirk 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

A Phase 3 placebo-controlled, double-bli

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

✍ Elmer Yu; Karen Miotto; Evaristo Akerele; Ann Montgomery; Ahmed Elkashef; Robert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 656 KB